|Bid||0.00 x 1300|
|Ask||27.00 x 900|
|Day's Range||20.89 - 21.99|
|52 Week Range||20.89 - 42.08|
|Beta (3Y Monthly)||1.79|
|PE Ratio (TTM)||23.89|
|Earnings Date||Feb 4, 2019 - Feb 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||32.77|
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Colfax Corporation (NYSE:CFX). Colfax Corporation (NYSE:CFX) investors should be aware […]
Matt Trerotola has been the CEO of Colfax Corporation (NYSE:CFX) since 2015. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider growth that Read More...
Colfax's (CFX) entry into the medical solutions industry, with the DJO Global buyout, will boost its earnings in the near term and strengthen its growth opportunities in the long run.
Industrial technology company Colfax Corp. revealed a plan Monday to significantly reshape its business, as it reached a deal to buy a medical-equipment maker for more than $3 billion and said it would explore strategic options for one of its two units. Colfax said it is buying DJO Global Inc. for $3.15 billion in cash. DJO, currently owned by Blackstone Group LP-managed private-equity funds, sells orthopedic-rehabilitation devices.
Colfax said it is exploring strategic options, including a sale, for its air and gas handling business, which makes compressors and turbines largely for oil and gas companies. The DJO deal, the company's biggest ever, moves it to a fast-growing industry familiar to its founders and chief executive officer. Brothers Steven and Mitchell Rales, who founded Colfax two decades ago, also built medical equipment company Danaher Corp (DHR.N), while CEO Matt Trerotola worked at Danaher before joining Colfax.
Moody's Investors Service ("Moody's") placed the ratings of DJO Finance LLC (DJO) under review for upgrade, including its Caa1 Corporate Family Rating, Caa1-PD Probability of Default Rating, B1 senior secured credit facility, Caa2 senior secured second lien notes and the Caa3 senior secured third lien notes. DJO's SGL-2 Speculative Grade Liquidity rating is unchanged.
Colfax Corp made a big bet on the medical device industry with its $3.15 billion purchase of DJO Global Inc, but its shares fell 15.2 percent as investors worried about its shift away from its industrial roots to a completely new sector. Colfax said it is exploring strategic options, including a sale, for its air and gas handling business, which makes compressors and turbines largely for oil and gas companies. The DJO deal, the company's biggest ever, moves it to a fast-growing industry familiar to its founders and chief executive officer.
Stocks that moved substantially or traded heavily Monday: Resolute Energy Corp., up $4.21 to $34.70 Cimarex agreed to buy the energy company for $35 a share in cash and stock. Colfax Corp., down $4.26 ...
Moody's Investors Service ("Moody's") affirmed Colfax Corporation's ("Colfax") Corporate Family Rating (CFR) at Ba2, the Probability of Default Rating at Ba2-PD and the senior unsecured ratings at Ba2. In addition, the Speculative Grade Liquidity (SGL) rating was affirmed at SGL-2. The affirmations and outlook change to negative follow Colfax's announcement to acquire DJO Global Inc. (DJO), a medical device company, for $3.15 billion in a largely debt-financed transaction.
DJO Global, which is based in Vista, California, will operate as a new segment within Colfax and be led by DJO CEO Brady Shirley.
Colfax’s biggest deal ever, based on data compiled by Bloomberg -- is a major foray into medical equipment for the maker of industrial pumps and valves. DJO’s products include casts and braces for fractures and other injuries, as well as far more complex surgical products, like replacement joints. Further changes could be on the way, said Colfax Chief Executive Officer Matt Trerotola, including getting out of the air-and-gas business.
Here are some of the companies with shares expected to trade actively in Monday’s session. Stock movements noted by ticker reflect movements during regular trading hours; premarket trading is specified separately.
Diversified technology company Colfax Corp. said Monday it has entered an agreement to acquire DJO Global Inc., a maker of orthopedic devices, from Blackstone for $3.15 billion in cash. The deal is expected to close in the first quarter of 2019 and to boost adjusted per-share earnings in the first full year after closing. It is expected to generate a tax benefit in the form of net operating loss carryforwards of $800 million. Colfax will finance the deal with about $100 million of cash, proceeds from credit facilities and a debt offering, along with $500 million to $700 million from equity or equity-linked securities. The deal "creates a new growth platform in the high-margin orthopedic solutions market," Chief Executive Matt Trerotola said in a statement. "As a clear market leader in bracing and rehabilitation systems -- with a track record of innovative new products, globally recognized brands, and a diverse product portfolio -- DJO is well-positioned to benefit from secular trends driven by changing demographics and increased preventive healthcare." Colfax shares were not yet active premarket, but have fallen 29.4% in 2018, while the S&P 500 has gained 2.3%.
Industrial equipment maker Colfax Corp said on Monday it would acquire medical device maker DJO Global Inc from private equity funds managed by Blackstone Group for $3.15 billion in cash. Colfax expects ...
Colfax Corporation (CFX), a leading diversified technology company, today announced it has entered into a definitive agreement to acquire DJO Global Inc. (“DJO”) from private equity funds managed by Blackstone for $3.15 billion in cash. DJO is a global leader in orthopedic solutions, providing orthopedic devices, software and services spanning the full continuum of patient care, from injury prevention to rehabilitation. “The acquisition of DJO is a compelling next step in the strategic evolution of Colfax that creates a new growth platform in the high-margin orthopedic solutions market,” said Matt Trerotola, President and Chief Executive Officer of Colfax.
Colfax Corporation (“Colfax”) (CFX), a leading diversified industrial technology company, today announced that it will be presenting at the 2018 Baird Global Industrial Conference in Chicago, Illinois on November 6, 2018 at 8:00am CST (9:00am EST). A live presentation of this event can be accessed via Colfax’s website at www.colfaxcorp.com under the “Investors” section. Colfax Corporation is a leading diversified industrial technology company that provides air and gas handling and fabrication technology products and services to customers around the world under the Howden and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves.
Colfax (CFX) delivered earnings and revenue surprises of 3.85% and -2.02%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Annapolis Junction, Maryland-based company said it had net income of 26 cents. Earnings, adjusted for one-time gains and costs, were 54 cents per share. The results surpassed ...
ANNAPOLIS JUNCTION, MD, Oct. 25, 2018 -- • Reported net income from continuing operations per diluted share of $0.29 versus $0.35 in the prior year.